EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL: Plan and Preliminary Results of a Two‐Year Feasibility Trial for a Multicenter Intervention Study to Evaluate the Benefits versus the Disadvantages of Treating Mild Hypertension: Prepared for the Veterans Administration‐National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension†

37Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Neurath, H. M., Goldman, A. I., Lavin, M. A., Schnaper, H. W., Fitz, A. E., Frohlich, E. D., … Richman, H. G. (1978). EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL: Plan and Preliminary Results of a Two‐Year Feasibility Trial for a Multicenter Intervention Study to Evaluate the Benefits versus the Disadvantages of Treating Mild Hypertension: Prepared for the Veterans Administration‐National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension†. Annals of the New York Academy of Sciences, 304(1), 267–287. https://doi.org/10.1111/j.1749-6632.1978.tb25604.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free